WST: West Pharma Kompaniya qiymatining sof foydaga nisbati

West Pharma Corp - WST emitenti grafik logotipi

West Pharmaceutical Services GLP-1 dori vositalariga bo'lgan talabdan foydalanib, inyektsiya komponentlarini yetkazib berish orqali daromad keltiradi. Kompaniyaning P/E baholash profili multiplikator dinamikasini aks ettiradi, bunda 46.00 qiymati ushbu darajani xarakterlaydi. Xatarlar sog'liqni saqlash gigantlarining ignasiz usullarga o'tish ehtimoli bilan bog'liq. FDA sertifikatsiyasiga yuqori bog'liqlik biznesning o'z nishasi doirasidagi ustun mavqeini mustahkamlaydi.

West Pharma (WST) Narxning foydaga nisbati: 04.07.2022 - 16.11.2026 davri uchun

West Pharmaceutical Services Inc (WST) kompaniyasining tahliliy kesimlari

- bozor kapitallashuvi haqida ma'lumot:
Kompaniyaning har tomonlama tahlili:West Pharmaceutical Services Inc - WST
West Pharma ishlab chiqargan mahsulot

West Pharmaceutical Services (WST) biznes modelini P/E koeffitsiyenti tarixiga tayanib tahlil qilish kompaniyaning bozor qiymatini uning sof foydasiga nisbatan baholash imkonini beradi. Ushbu ko'rsatkich investitsiyalarning qoplanish muddatini o'lchab, kelajakdagi pul oqimlariga nisbatan bozor kutganlarini aks ettiradi. Matematik jihatdan, ushbu metrika umumiy kapitalizatsiyani yillik daromad bilan bog'lab, zichlash tizimining noyobligi uchun premiumni namoyish etadi. Sog'liqni saqlash gigantlarining FDA sertifikatsiyasiga kuchli bog'liqligi ushbu koeffitsiyentni raqobatga chidamli qiladi.

Raqobatdosh kompaniyalar

P/E multiplikatori Intuitive Surgical, Inc.|Narx-foyda koeffitsiyenti DHR (Danaher Corp)|BDX (Becton, Dickinson and Company) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori STE (steris.com)|Biznesning o‘zini qoplash muddati baxter.com (BAX)|Masimo Corp - P/E multiplikatori|Biznesning o‘zini qoplash muddati Stevanato Group SpA STVN|Teleflex Corp (TFX) - Narxning foydaga nisbati|Narx-foyda multiplikatori MMSI|Narxning foydaga nisbati envistaco.com|ICU Medical (ICUI) - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti XRAY (DENTSPLY SIRONA Inc.)|Bozor narxining sof foydaga nisbati LMAT|Narxning foydaga nisbati AtriCure Corp ATRC|Kompaniya qiymatining sof foydaga nisbati STAA|NAGE: Narx-foyda koeffitsiyenti|ZIMV - P/E multiplikatori|AngioDynamics Inc (ANGO) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Cerus|TKNO (teknova.com) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Monogram Orthopedics Inc. MGRM|Narxning foydaga nisbati Sharps Tech (STSS)|InfuSystem Inc - Narx-foyda multiplikatori|Utah Medical Products - Narx-foyda koeffitsiyenti|Bozor narxining sof foydaga nisbati KRMD (KORU Medical Systems)|NYXH - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati Microbot Medical, Inc MBOT|Pro-Dex Corp (PDEX) - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati ZTEK (Zentek Ltd.)|Narxning foydaga nisbati Elutia|Milestone Scientific Inc (MLSS) - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti NXGL (NEXGEL, Inc.)|RVP (Retractable Technologies, Inc.) - Kompaniya qiymatining sof foydaga nisbati|Harvard Bioscience, Inc. - Narx-foyda koeffitsiyenti|P/E multiplikatori femasys.com FEMY|MHUA: Narx-foyda koeffitsiyenti|Biznesning o‘zini qoplash muddati predictive-oncology.com POAI|Callan JMB Inc (CJMB) - Narxning foydaga nisbati|Narx-foyda multiplikatori ATRI|NURO (NeuroMetrix Inc) - P/E multiplikatori